Sawaf Aziz (CIK 0001961289)

Latest company ownership

TBPH - Theravance Biopharma, Inc.

Role: CFO

Shares held

336,795

Last filed at

Nov 24, 2025

Confidence Score

40.6

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 20, 2025	Nov 24, 2025	Theravance Biopharma, Inc.	CFO	Sell	40.0	-18,627	-5.24%	✗	$333.4K
Aug 20, 2025	Aug 22, 2025	Theravance Biopharma, Inc.	CFO	Sell	42.5	-9,368	-2.57%	✗	$125.4K
May 20, 2025	May 22, 2025	Theravance Biopharma, Inc.	CFO	Sell	42.5	-9,348	-2.50%	✗	$88.3K
Feb 20, 2025	Feb 24, 2025	Theravance Biopharma, Inc.	CFO	Sell	42.5	-13,751	-4.39%	✗	$132.8K
Nov 20, 2024	Nov 22, 2024	Theravance Biopharma, Inc.	CFO	Sell	42.5	-8,477	-2.64%	✗	$84.5K
Aug 20, 2024	Aug 22, 2024	Theravance Biopharma, Inc.	CFO	Sell	42.5	-8,635	-2.62%	✗	$71K
May 20, 2024	May 22, 2024	Theravance Biopharma, Inc.	CFO	Sell	42.5	-8,635	-2.55%	✗	$78.6K
Feb 20, 2024	Feb 22, 2024	Theravance Biopharma, Inc.	CFO	Sell	42.5	-17,036	-6.66%	✗	$152K
Nov 20, 2023	Nov 22, 2023	Theravance Biopharma, Inc.	CFO	Sell	42.5	-6,187	-2.36%	✗	$64.2K
Aug 20, 2023	Aug 22, 2023	Theravance Biopharma, Inc.	CFO	Sell	42.5	-7,114	-2.64%	✗	$69K
May 20, 2023	May 23, 2023	Theravance Biopharma, Inc.	CFO	Sell	42.5	-8,744	-3.15%	✗	$98K
Feb 20, 2023	Feb 22, 2023	Theravance Biopharma, Inc.	CFO	Sell	42.5	-6,783	-3.32%	✗	$70.8K